Opiod induced respiratory depression can be reversed with
**Core Concept**
Opioid-induced respiratory depression is a life-threatening condition that requires immediate reversal. This condition is caused by the activation of **mu (μ) opioid receptors** in the brain, which leads to a decrease in respiratory rate and depth. The reversal of this condition involves the use of specific medications that can counteract the effects of opioids.
**Why the Correct Answer is Right**
The correct answer is a medication that acts as a **mu (μ) opioid receptor antagonist**, which can effectively reverse opioid-induced respiratory depression. This medication works by binding to the **mu (μ) opioid receptors** and blocking the action of opioids, thereby increasing respiratory rate and depth. The most commonly used medication for this purpose is **naloxone**, which is a potent **mu (μ) opioid receptor antagonist**.
**Why Each Wrong Option is Incorrect**
**Option A:** Is incorrect because it is not a **mu (μ) opioid receptor antagonist**.
**Option B:** Is incorrect because it is not typically used to reverse opioid-induced respiratory depression.
**Option C:** Is incorrect because it is not a medication.
**Option D:** Except for the correct answer, all other options are incorrect as they do not effectively reverse opioid-induced respiratory depression.
**Clinical Pearl / High-Yield Fact**
It is essential to remember that **naloxone** is a short-acting medication, and repeated doses may be necessary to reverse opioid-induced respiratory depression. Additionally, **naloxone** should be administered cautiously, as it can precipitate withdrawal symptoms in individuals who are physically dependent on opioids.
**Correct Answer:** D. Naloxone.